Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 27477525

Enzalutamide in Men with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer: Extended Analysis of the Phase 3 PREVAIL Study.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Eur Urol
Publication date
2017 Feb
First author
Beer TM

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Beer TM
      type
      Author
    2. name
      Armstrong AJ
      type
      Author
    3. name
      Rathkopf D
      type
      Author
    4. name
      Loriot Y
      type
      Author
    5. name
      Sternberg CN
      type
      Author
    6. name
      Higano CS
      type
      Author
    7. name
      Iversen P
      type
      Author
    8. name
      Evans CP
      type
      Author
    9. name
      Kim CS
      type
      Author
    10. name
      Kimura G
      type
      Author
    11. name
      Miller K
      type
      Author
    12. name
      Saad F
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Beer TM
      type
      Author
    2. name
      Armstrong AJ
      type
      Author
    3. name
      Rathkopf D
      type
      Author
    4. name
      Loriot Y
      type
      Author
    5. name
      Sternberg CN
      type
      Author
    6. name
      Higano CS
      type
      Author
    7. name
      Iversen P
      type
      Author
    8. name
      Evans CP
      type
      Author
    9. name
      Kim CS
      type
      Author
    10. name
      Kimura G
      type
      Author
    11. name
      Miller K
      type
      Author
    12. name
      Saad F
      type
      Author
    bibliography ids
    1. nci-bib-d24437086f6e260dd32e67d2
    book metadata
    content sha256
    8950aa38c0c1970577dfa0e36159253d6617342b8b3ed6b8e3a4986bac29162b
    document type
    citation
    dois
    1. 10.1016/j.eururo.2016.07.032
    electronic publication date
    display
    2016 Jul 28
    precision
    day
    year
    2016
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:27477525
    immutable id
    pubmed:27477525@8950aa38c0c1970577dfa0e36159253d6617342b8b3ed6b8e3a4986bac29162b
    journal
    abbreviation
    Eur Urol
    issn electronic
    1873-7560
    issn print
    0302-2838
    issue
    2
    name
    European urology
    nlm unique id
    7512719
    pages
    151-154
    volume
    71
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      27477525
      provenance
      batch id
      d649bcb2d98dbbacd53c
      provider
      NCBI PubMed ESummary
      record sha256
      59c25e1cbeb79f95e6f0e7e1c28ff523546d6d1b48591ba76d9112c75cc963a6
      response sha256
      26648a40f123f366675007f51cc29befd1f9a89273ca2da87c477c54d2d15d20
      retrieved at
      2026-09-09T23:47:20.761544+00:00
      publication date
      display
      2017 Feb
      precision
      month
      year
      2017
      publication types
      1. Clinical Trial, Phase III
      2. Journal Article
      3. Randomized Controlled Trial
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/27477525/
      title
      Enzalutamide in Men with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer: Extended Analysis of the Phase 3 PREVAIL Study.

      Preserved source evidence · Not medical advice